INNOVATE BIOPHARMACEUTICALS INC

INNT NASDAQ
1.350
+0.100
+8.00%
盘后: 1.350 0 0.00% 18:13 05/24 EDT
开盘
1.260
昨收
1.250
最高
1.350
最低
1.230
成交量
39.65万
成交均量(3M)
97.73万
52周最高
29.09
52周最低
1.230
换手率
15.44%
市值
346.83万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供INNOVATE BIOPHARMACEUTICALS INC INNT股票价格,INNOVATE BIOPHARMACEUTICALS INC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and INN-329 (Secretin). The Company’s INN-108 is a novel small molecule comprised of two active parts with anti- inflammatory and immunodulatory properties coupled through an azo bond. The Company is developing INN-108 as a therapeutic for Ulcerative Colitis (UC). Its Secretin stimulated magnetic resonance cholangiopancreatography (MRCP) is a ionizing, radiation-free assessment of the pancreaticobiliary system. The Company has completed a phase II b clinical trial for celiac disease for INN-202. It is developing INN-108 in a phase II trial for inflammatory bowel disorders, mild to moderate UC and a Gastrointestinal (GI) orphan disease.
展开 >

最近浏览

名称
价格
涨跌幅